COVID News

As pharma companies race to release a vaccine for young children, parents say they're not totally on board just yet. Here's where most American parents stand.

If you're considering taking a trip abroad in the near future, it's important to know what to expect in the event that you test positive for COVID-19 overseas.

While Paxlovid has been shown to have incredible results in reducing the severity of COVID-19 symptoms, there are certain limitations to its power.

Irish researchers conducted two studies exploring how clinical interventions such as occupational therapy affect participants coping with symptoms of long COVID

Moderna may be close to getting emergency authorization for a vaccine designed for America's youngest children. Here's what you need to know.

As if symptoms of COVID-19 weren't rough enough on your health, up to 30% of people end up with long COVID. What treatments are being tested for these people?

A new Omicron subvariant has been detected, deemed the Omicron BA.2.12.1 variant. Here's what you need to know about the latest COVID-19 news.

A vaccine that may provide better protection against new variants, called Valneva, is undergoing regulatory approval. Here's what you need to know.

Although measles is preventable, experts are warning of the potential for massive outbreaks. Millions of children are not receiving their routine vaccinations.

The U.S. has entered a 'transition phase' of the pandemic, according to White House chief medical advisor Dr. Anthony Fauci. Here's what it means for us all.

We've detailed everything you need to know about Vice President Kamala Harris testing positive for COVID-19 on Tuesday.

This past winter, when it felt like practically everyone was getting Covid-19, data indicates that it turns out that many people actually did.

A new study investigated the likelihood of vaccinated people contracting COVID-19. Here's what it found about who is more and less likely to experience it.

Taking Paxlovid within the first five days of COVID-19 symptoms can reduce risk of hospitalization and death by 89%, but the pill is under-prescribed.

COVID-19 is a high-risk way of getting immunity and is less effective for omicron. So what role does the immune system actually play in vaccine effectiveness?

There have been questions and mixed messages around who should be getting a second COVID-19 booster shot and when to get them. Here's the latest guidance.

A new study published in JAMA Network Open reveals that people with mental health problems might be at a greater risk of developing breakthrough COVID-19 cases.

Health experts want everyone to consider taking this very important step with at-home test kits to ensure the safety and health of you and those around you.

A new study has tracked the efficacy of the Pfizer, Moderna, and Johnson & Johnson vaccines to see which provides the greatest level of antibody protection.

Unfortunately, many scientists are beginning to have doubts about whether humans will be able to reach COVID-19 herd immunity, at least any time soon.

According to the latest health news, the FDA has approved a new way to test for COVID-19 that may replace the nose swab. Here's what you need to know.

The Biden administration officially extended the Covid-19 public health emergency for another 90 days, which can help millions of Americans.

While vaccines are the best way to COVID-19 infection, there are other treatments. Here's why one treatment against COVID-19 remains unused in hospitals.

Here's how to self-assess your risk for coronavirus infection if you're considering whether or not it's safe to partake in more social activities.

This week, the WHO announced that it is now tracking two new subvariants of the Omicron strain, BA.4 and BA.5. Here's what you need to know.

While restrictions are easing, researchers are now looking for ways to prevent symptomatic COVID-19 cases. Nasal sprays may be a promising possibility.

New research reveals that COVID-19 increases your risk for blood clots and other conditions longer than you think. Here's what you need to know.